Sajulga, Annie Rose .

HRN: 03-75-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2025
METRONIDAZOLE 500MG (TAB)
04/09/2025
04/16/2025
PO
500mg
TID
Thickly Msaf
Waiting Final Action 
04/09/2025
CEFUROXIME 500MG (TAB)
04/09/2025
04/16/2025
PO
500mg
BID
Thickly Msaf
Waiting Final Action 
04/09/2025
AMPICILLIN 1GM (VIAL)
04/09/2025
04/15/2025
IV
2g
Q6
UTI
Waiting Final Action 
04/09/2025
CO-AMOXICLAV 625MG (TAB)
04/10/2025
04/15/2025
PO
1tab
Bid
Uti, Thickly Msaf
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: